Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

U.K. warns against using arstolochia

This article was originally published in The Tan Sheet

Executive Summary

U.K. consumers should not use Xie Gan Wan pills, a Chinese product containing aristolochia, an unlicensed medicine the country banned in 1999, according to a Medicines and Healthcare products Regulatory Agency alert. MHRA identified a number of other products in recent years containing aristolochia, which can cause kidney failure. In 2004, California added aristolochic acid and other herbal remedies containing plant species of the genus aristolochia to the list of chemicals known to cause cancer (1"The Tan Sheet" July 12, 2004, In Brief)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103978

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel